Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IL16 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | EPB41 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | MFSD14A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
mRNA | OR13C5 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
mRNA | PAQR7 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
mRNA | EXT2 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.009 |
mRNA | LYRM2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
mRNA | CD209 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
mRNA | MCHR2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
mRNA | TNFAIP1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |